BioNTech SE ADR buy skatcup
Start price
23.01.23
/
50%
€131.45
Target price
23.01.24
€100.00
Performance (%)
-30.00%
End price
24.01.24
€92.02
Summary
This prediction ended on 24.01.24 with a price of €92.02. The price of BioNTech SE ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -30.00%. skatcup has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
BioNTech SE ADR | 7.896% | 7.896% | 243.124% |
iShares Core DAX® | -0.116% | 1.953% | 14.155% |
iShares Nasdaq 100 | -2.733% | -1.273% | 31.828% |
iShares Nikkei 225® | -1.721% | 3.263% | 12.922% |
iShares S&P 500 | -1.527% | 0.194% | 27.117% |
According to skatcup what are the pros and cons of BioNTech SE ADR for the foreseeable future?
Pros
Rising EBIT margin expected
Good rating
High Investments for future growth
Valuable balance sheet
Strong uniques
Growths much faster than the competition
Stable Large shareholder and/or long term investor
Medium risks for its business
Market Leader or Top 3
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Very capable Management
Very good company culture
Innovative
Small cyclical dependencies
Well known brand
Could be worthwhile Investment >10% per year
positive Cash Flow expected
Normal challenges to pay loans and raise capital
Cons
Comments by skatcup for this prediction
In the thread Biontech SE diskutieren
Buy mit Kursziel 200,0
Kursziel geändert auf 130,0
Kursziel geändert auf 100,0
In the thread Trading Biontech SE
Die von skatcup gewählte maximale Laufzeit wurde überschritten
Stopped prediction by skatcup for BioNTech SE ADR
BioNTech SE ADR
Start price
Target price
Perf. (%)
€134.45
25.01.22
25.01.22
€200.00
25.01.23
25.01.23
16.36%
05.02.22
05.02.22
Rising EBIT margin expected
Good rating
High Investments for future growth
Valuable balance sheet
BioNTech SE ADR
Start price
Target price
Perf. (%)
€83.96
09.01.21
09.01.21
€300.00
09.01.22
09.01.22
124.99%
10.01.22
10.01.22
Rising EBIT margin expected
Good rating
High Investments for future growth
Valuable balance sheet
BioNTech SE ADR
Start price
Target price
Perf. (%)
€77.54
05.11.20
05.11.20
-
05.11.21
05.11.21
20.98%
27.11.20
27.11.20
Rising EBIT margin expected
Good rating
High Investments for future growth
Valuable balance sheet